Findings from Boehringer Ingelheim’s recent rollout of AI in Pharmacovigilance (PV)
20 June 2025
No Comments
What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable
Tag: GenAI
